trending Market Intelligence /marketintelligence/en/news-insights/trending/ukyiT9GJevhOy900bKxCfA2 content esgSubNav
In This List

Tracon Pharmaceuticals to sell $15M of common shares to private fund

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022


Tracon Pharmaceuticals to sell $15M of common shares to private fund

Tracon Pharmaceuticals Inc. agreed to sell common shares for up to $15 million to Chicago-based private fund Aspire Capital Fund LLC over a period of 30 months.

San Diego-based biotechnology company Tracon issued 1,426,579 common shares to the asset management firm as consideration for entering into the agreement.

Tracon plans to use the proceeds to advance its potential drugs pipeline and product development platform. Funds will also be used for general corporate purposes.

Under the agreement, Tracon will be eligible to make requests to Aspire Capital for the purchase of shares. Moreover, Aspire Capital cannot ask Tracon to sell any shares.

Tracon holds the right to terminate the agreement at any time without any additional cost or penalty.